Introduction
Incubation of primary cultures of macrophages with oxidized LDL (ox-LDL)' was shown to induce lipid loading (1, 2) .
After long-term incubation with ox-LDL, most of this lipid is contained within lysosomes, primarily in the form of lipid-protein complex called ceroid (3) . By contrast, macrophage degradation of acetylated LDL (acetyl-LDL) results in cellular accu-mulation of cholesteryl oleate droplets in the cytoplasm (4) . Recently, several groups have shown that following internalization of ox-LDL by macrophages, apo B, the protein portion of the LDL, was poorly degraded within cellular lysosomes (5) (6) (7) (8) . Additionally, it was shown that the poor proteolysis of ox-LDL also occurred in cell-free systems such as extracts of mouse peritoneal macrophages (MPM) (7, 8) , or with mixtures of cathepsin B and D (6, 9) . Reduction in proteolysis was shown to correlate with the degree of oxidation (8) . It was shown that proteolysis by lysosomal enzymes decreased with increasing degree of crosslinking of apo B in LDL that was induced using 4-hydroxynonenal (HNE) (8) . These authors reasoned that the deficient degradation of apo B in ox-LDL was due to a reduced susceptibility of the modified portions of apo B in ox-LDL to proteolysis.
An alternative explanation for this poor processing of ox-LDL protein is that the ox-LDL is directly able to inactivate lysosomal proteases. Several reports have appeared showing that reactive aldehydes, such as HNE, formed by the decomposition of hydroperoxides ( 10) , can form covalent linkages with enzymes, thereby inactivating them (10) (11) (12) . This is particularly true of enzymes with active sites containing thiol groups, because thiol-ether adducts can be formed by the Michael addition mechanism (11, 12) .
In this report, we attempted to assess whether lysosomal protease inactivation could be, in part, responsible for this deficient processing. Three approaches have been used. First, we asked whether preincubation of MPM with ox-LDL affected the subsequent degradation of other lipoproteins (LPs). Second, we ascertained whether extracts of cells that had been preincubated with ox-LDL demonstrated a reduction in proteolytic activity. And third, we determined whether ox-LDL could directly affect the proteolytic activity of cell extracts or purified proteases.
Methods
Materials. Cathepsin B (EC 3.4.22.1) (C 6286), cathepsin D (EC 3.4.23.5) (C 3138), Na-CBZ-L-lysine p-nitrophenyl ester (CLN) (C 3637), fatty acid-free BSA, butylated hydroxytoluene (BHT), TCA, DTT (9) . Cells were washed with serum-free RPMI and the indicated concentration of unlabeled native or modified LDL added in 250 Ml of the medium containing FCS as described above. After overnight incubation, cells were washed and incubated with labeled native or modified LDL for another 5 h. The media were then removed and assayed for TCA-soluble, noniodine degradation products according to the procedure described previously (5, 9) . Cells were washed three times with PBS, dissolved in 0.25 N NaOH, and assayed for cell-associated label and protein content. Total uptake was calculated from the sum of degradation and cell-associated label. All determinations are reported as mean+SD of triplicate determinations.
Proteolytic activity of macrophage extracts. MPM were isolated from thioglycollate-elicited mice as described above. Cells were grown in 100-mm Petri dishes (20 x 106/dish) and incubated for 18 h in medium alone or medium containing native or modified LDL at the indicated concentrations. At the end of the incubation, macrophage monolayers were washed twice with PBS followed by one wash with 250 mM sucrose, 1 mM Na2EDTA, and 0.1% ethanol, pH 6.8. Scraped cells were pelleted by centrifugation at 2,000 g for 10 min and resuspended in 1 ml of the sucrose solution described above. Then, the cells were ruptured by passing 10 times through a 30-gauge needle, followed by 10 cycles of freezing and thawing, and finally by two 15-s bursts of sonication (8) . The homogenates were spun again at 5,000 g to remove particulate matter and supernatant fractions, defined in this study as cell extracts, were collected, aliquoted, frozen at -70°C, and subsequently used in experiments over a period of 2 mos. 5 Aig of cell extract protein was mixed with the indicated concentrations of '251I-LDL in a final volume of 100 al of 100 mM sodium acetate, 1 mM Na2EDTA, and 1 mM DTT, pH 4.0, and incubated for 1.5 h at 37°C. The degradation of the radioactive substrate was measured as TCA-soluble, noniodine radioactivity. Cathepsin B activity of macrophage extracts was assayed as follows: 0.5 og of extract was mixed with 500 81I of acetate buffer, pH 4.0, containing CLN at a final concentration of 2 x 10' M and absorbance at 326 nm monitored over a 30-min time interval (18) . To determine the proteolytic activity of enzymes that have been stimulated by the addition of DTT, we conducted all experiments in the presence and absence of DTT. DTT-dependent proteolysis was determined as total degradation (DTT present) minus DTT-independent degradation (DTT omitted).
Cathepsin degradation. Digestion of LPs by cathepsins B and D was performed as described by Lougheed et al. (6) Analytic procedures. The protein content of LPs cells, and cell extracts was measured in triplicate by the bicinchoninic acid assay using BSA as a standard (20) . Samples were diluted in 1% SDS to minimize turbidity. Samples were incubated for 60 min at 60°C, and absorbance was measured at 595 nm.
Results
Effect ofpreincubation ofMPM with ox-LDL on the subsequent degradation of "2'IMlabeled lipoproteins. To determine whether uptake of ox-LDL by MPM affected the degradation of subsequently internalized LPs, we first incubated MPM under various conditions for 21 h, removed the medium, and then incubated the cells with medium containing different 251I-LP for 5 h to determine the rates of cellular LP degradation. Since extensively oxidized LDL consists of soluble and insoluble portions (9) , in initial experiments we studied the effect of these two forms of ox-LDL separately.
We first compared the effect of preincubation of MPM with insoluble ox-LDL, LDL, or medium alone on the subsequent degradation of 1251-insoluble ox-LDL. Insoluble ox-LDL greatly inhibited the subsequent degradation of '251-insoluble ox-LDL (Fig. 1 a) , whereas preincubation of cells with LDL failed to inhibit this degradation relative to medium alone (not shown). Since incubation with insoluble ox-LDL led to substantial intracellular accumulation of unprocessed LP (9), we compared the effect of preincubation with insoluble ox-LDL on subsequent LP degradation with that of preincubation with LDL made insoluble by vortex aggregation (vx-LDL) as a control for the accumulation of undegraded but nonoxidized LP. We found that cells preincubated with vx-LDL did not inhibit the degradation of either '251-insoluble ox-LDL or '25I-vx-LDL (Fig. la) . Since the preincubation of cells with unlabeled vx-LDL had no effect on the degradation of subsequently added '251-vx-LDL, it is unlikely that a transient overloading of the lysosomal degradation system was responsible for the inhibition in degradation of ox-LDL by preincubating cells with ox-LDL. To determine whether induction of phagocytosis was responsi- ble for this inhibition, we preincubated cells with opsonized latex beads. Again, no reduction in the degradation of either 1251-insoluble ox-LDL or '251-vx-LDL was observed (not shown), indicating that phagocytosis, per se, was not responsible for this reduced degradation.
We also wished to assess whether soluble ox-LDL was also able to inhibit subsequent degradation of itself. As in the case with insoluble ox-LDL, preincubation of MPM with soluble ox-LDL, in contrast to vx-LDL, inhibited the subsequent degradation of either labeled soluble ox-LDL or vx-LDL (Fig. 1 b) did not differ significantly from the preincubation with LDL (0.1±0.02 dig/mg cell protein). Thus, ox-LDL is able to inhibit the degradation of not only ox-LDL but other LPs as well. To assess whether the described reduction in degradation was the result of decreased lysosomal degradation or uptake, possibly the result of inhibition of phagocytosis of insoluble LP, we determined the effect of preincubation of MPM with ox-LDL on LP uptake. After preincubating MPM with soluble or insoluble ox-LDL as well as with LDL, no major reduction in the subsequent uptake of any of the labeled LP employed was found (Fig. 2) , suggesting that this inhibition in LP degradation was probably at the level of lysosomal degradation and not on the uptake mechanism. Treatment of MPM with ox-LDL for 21 h did not lead to any loss of cell protein or any significant changes in MPM morphology, suggesting a lack of any general toxicity of ox-LDL on MPM under the conditions employed.
To determine whether insoluble ox-LDL and soluble ox-LDL were equally effective in inhibiting the degradation in MPM of subsequently added LP, we added different concentrations of each to cells and assessed their relative effects on the degradation of 1251-insoluble ox LDL. As seen in Fig. 3 a, 25 ,4g/ml of insoluble ox-LDL was as effective as 100 tig/ml of soluble ox-LDL in inhibiting the degradation of '251-insoluble ox-LDL relative to preincubation with medium alone. We also determined in a parallel experiment the uptake of '25I-soluble and insoluble ox-LDL after incubation of MPM for 21 h. As seen in Fig. 3 b, the uptake of 25 ,ug/ml of insoluble ox-LDL was about the same as that of 100 .tg/ml of soluble ox-LDL.
Thus, when normalized for equivalent degrees of uptake, it appears that soluble and insoluble ox-LDL had about equal abilities to inhibit the degradation of other LP, consistent with the similar degree of oxidation. Based on these results, we have described the effects of ox-LDL generically in the studies described below.
Since preincubated with ox-LDL showed a major decrease in lysosomal thiol protease activity; i.e., degradation of LDL at pH 4.0 (Fig. 4) was assessed as DTT-dependent proteolysis. Similar levels of inhibition in thiol protease activity were found for the cells pretreated with soluble and insoluble ox-LDL when normalized for equivalent uptakes using values in Fig. 3 .
To assess the activity of thiol proteases directly, CLN was used ( 18) as a specific substrate for cathepsin B, a thiol protease. Cathepsin B, along with cathepsin D, an aspartic protease, was shown to be a principal enzyme responsible for lysosomal digestion of LDL (6) . MPM (Fig. 4) .
Effect of ox-LDL on protease activity in extracts of untreated MPM and mixtures of cathepsin B and D. To explore whether or not the documented reduction of proteolytic activity in MPM by ox-LDL was the result of direct interaction of ox-LDL with the enzyme, we incubated extracts from control macrophages with various forms of modified LDL. We found that ox-LDL, but not acetyl-LDL or vx-LDL, caused a significant decrease in DTT-sensitive proteolysis of '"I-LDL (Fig.   5 ). Both soluble and insoluble ox-LDL reduced thiol protease activity to the same degree (not shown).
To more specifically investigate whether ox-LDL can inactivate cathepsins B and D, we compared the relative abilities of different forms of modified and unmodified LDL to inhibit these enzyme activities in a 1:1 mixture of cathepsin B and D using the CLN assay for cathepsin B activity ( 18 ) and the degradation of labeled hemoglobin as an indicator of cathepsin D activity (19) . Ox-LDL, but not other forms of LDL, induced an extensive reduction in cathepsin B activity (Fig. 6) . However, degra- dation of '25I-hemoglobin was unaffected by the presence of any of the LPs tested, suggesting that, unlike cathepsin B, cathepsin D appears to be resistant to inactivation by ox-LDL. Both soluble and insoluble ox-LDL were able to specifically inhibit cathepsin B in this assay to about the same degree (not shown).
We compared extent of degradation of 125I-LDL or 1251_ox_ 125I-LDL (Fig. 7 a) , which could also be explained by the greater reduction in cathepsin B activity when the mixture of cathepsin B and D was incubated with '25I-ox-LDL than when incubated with 125I-LDL (Fig. 7 b) . Similar results were obtained with soluble and insoluble ox-LDL (not shown). The gradual reduction of cathepsin B activity with increasing time in the presence of LDL probably reflects some self-inactivation of cathepsins during the prolonged incubation period.
Discussion
In this study we have examined whether inactivation of lysosomal proteases by ox-LDL is responsible for the poor degrada- (6) .
We have shown that ox-LDL inhibits thiol proteases in extracts of untreated MPM and cathepsin B in a mixture of cathepsin B and D. This result lends support to the hypothesis that ox-LDL inactivates the enzyme, whereas exposure of enzymes with LDL or vx-LDL causes no inactivation. Since both soluble and insoluble ox-LDL were about equally effective in inhibiting cathepsin B, it is unlikely that physical parameters such as particle aggregation play a role in the underlying mechanism. It still needs to be determined whether LDL oxidized to increasing degrees shows an increasing potency to inactivate cathepsin B.
One potential mechanism for enzyme inactivation is by covalent interaction of components of ox-LDL such as HNE with the enzyme ( 10-12). HNE was shown to form crosslinks with a number of amino acid side chains (10) . Both HNE-lysine adducts ( 10) and thiol-ether adducts ( 11, 12) have been identified. Recently, thiol-ether adducts between HNE and enzymes with a thiol group at their active site were shown to form, resulting in inactivation of the enzyme (11, 12) . It is possible that reactive aldehydes present in ox-LDL might form thiolether linkages with the thiol group at the active site of cathepsin B, and thereby inactivate the enzyme. Inactivation of cathepsin B by this mechanism would also be consistent with the rapid rate of reduction in enzyme activity following incubation with ox-LDL.
The rationale for performing these studies was to determine whether enzyme inactivation, in addition to substrate modification, plays any role in the deficient degradation of apo B in ox-LDL. Since increasing inter-and intramolecular crosslinking of apo B, either in extensively oxidized LDL (21) or in HNEmodified LDL (22) , was shown to parallel increasing degrees of poor degradation of LDL (8) , it was suggested that substrate modification was responsible for the poor protease degradation of modified apo B (8) . However, in our study, when samples of mixtures of cathepsin B and D that had been incubated with ox-LDL were removed during the course of incubation over a 24-h time interval and assessed independently for protease activity, the cathepsin B activity in these samples decreased in parallel with the reduction in ability of the mixture to degrade 1251-ox-LDL. This result suggests that the reduced degradation of ox-LDL could have been due to inactivation of cathepsin B by the ox-LDL.
In this study we found that the degradation of 1251-acetyl-LDL in MPM appeared to be less affected by preincubation with ox-LDL than the degradation of other LP. Similar results had been reported by other investigators (6, 8) . Both ligands have been shown to be internalized by the scavenger receptor (2) , but others have claimed that ox-LDL is also recognized by a unique receptor (5, 23) . The different degradation rates could be explained by different intracellular routing of the two ligands.
In summary, we have shown by combinations of studies in cell and cell-free systems that ox-LDL can inhibit the degradation of not only subsequently added ox-LDL but also other LPs as well, and that this inhibition is likely the result of inactivation of cathepsin B activity by the ox-LDL. These results have potentially important pathophysiological repercussions; namely, that if tissue macrophages internalize ox-LDL in atherosclerotic lesions, their capacity to degrade various LP may be impaired. Thus, lipid loading of these cells could occur not only by the accumulation of undegraded ox-LDL, but also by the accumulation of undegraded forms of other LP. Further studies are needed to establish the mechanisms responsible for these events.
